Hem › Medulloblastom › Florida
Kliniska studier för Medulloblastom i Florida
6 studier för Medulloblastom söker deltagare vid platser i Florida.
Städer i Florida
Officiell studietext (engelska)
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Orlando Health Arnold Palmer Hospital for Children, Orlando
- St. Joseph's Children's Hospital, Tampa
RekryterarFas 2
59 Months · Alla kön · Uppdaterad 15 sep. 2026 · NCT05535166Digoxin Medulloblastoma Study
- Nemours Jacksonville, Jacksonville
- University of Miami, Miami
- Johns Hopkins All Children's, St. Petersburg
- och 1 fler
RekryterarFas 2
12 Months – 30 Years · Alla kön · Uppdaterad 26 aug. 2026 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Golisano Children's Hospital of Southwest Florida, Fort Myers
- Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
- Nemours Children's Clinic-Jacksonville, Jacksonville
- och 7 fler
RekryterarFas 3
Ålder 4 till 21 · Alla kön · Uppdaterad 25 aug. 2026 · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Nicklaus Children's Hospital, Miami
RekryterarFas 2
Ålder 3 till 39 · Alla kön · Uppdaterad 24 aug. 2026 · NCT05096481DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- All Children's Hospital Johns Hopkins Medicine, St. Petersburg
- och 1 fler
RekryterarFas 2
Upp till ålder 21 · Alla kön · Uppdaterad 12 aug. 2026 · NCT04696029Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma
- University of Florida Health, Gainesville
RekryterarFas 1
Ålder 4 till 30 · Alla kön · Uppdaterad 7 aug. 2026 · NCT06514898Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.